HEALTH● LOWJul 13 · Jul 13, 2026, 7:15 AM
Faron Pharmaceuticals : Faron Provides Update on Investigator - Initiated Trial Portfolio for Bexmarilimab
finanznachrichten.de · Germany
Faron Pharmaceuticals has provided an update on its portfolio of investigator-initiated trials for the drug Bexmarilimab. This concerns ongoing research and development within the pharmaceutical sector.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More from Germany
POLITICS3h agoGermany expels 21-year-old Russian citizen of Yazidi descent who narrowly avoided deportation to Russia, where activists say he risked conscriptionMeduza [en]POLITICS7h agoGermany’s Merz vows to fight on: ‘We are the firewall’Financial TimesPOLITICS8h agoHamburg court sentences Iranian agents over plans to attack Jewish leaders in GermanyDW News [en]POLITICS9h agoWhat you need to know about Germany’s planned tax on sugary drinksEuroNews [en]
More in Health
HEALTH46m agoMore workers are skipping doctor's visits over money worriesCBS NewsHEALTH1h agoLetter : Utah should invest in student mental healthsltrib.com · United StatesHEALTH2h agoNCDs fastest-growing disease burden in Nigeria — OfficialPremium TimesHEALTH2h agoFG ‘revitalises’ 4,434 PHCs, expands access to quality healthcare servicesPremium Times